Targeted treatments extend survival in pancreatic cancer

A precision medicine approach to therapy significantly extended survival for patients with pancreatic cancer compared with standard chemotherapy, according to results of a retrospective study published in The Lancet Oncology.The findings suggest that molecularly guided treatments that target oncogenic drivers and the DNA damage response and repair pathway deserve further prospective study, researchers wrote.“[Pancreatic cancer] is a notoriously difficult disease to treat, and many of the promising therapies, including immunotherapy, have not yet made any impact on most patients withRead More

Share on facebook
Share on twitter
Share on linkedin